+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sangamo Therapeutics Inc - logo

Sangamo BioSciences is a biotechnology company that develops industry leading technologies in gene therapy, genome editing, cell therapy and gene regulation. The company is focused on pioneering genetic cures for monogenic and infectious diseases by deploying its AAV-based gene therapy platform, and therapeutic genome editing and gene regulation platforms based on its novel zinc finger DNA-binding protein technology. Sangamo is headquartered in Richmond, California.

Regenerative Medicine - Thematic Research - Product Thumbnail Image

Regenerative Medicine - Thematic Research

  • Report
  • November 2019
  • 24 Pages
  • Global
From
Fabry Disease - Pipeline Review, H2 2020 - Product Thumbnail Image

Fabry Disease - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 126 Pages
  • Global
From
Alpha L-Iduronidase - Pipeline Review, H2 2020 - Product Thumbnail Image

Alpha L-Iduronidase - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 66 Pages
  • Global
From
Phenylketonuria (PKU) - Pipeline Review, H2 2020 - Product Thumbnail Image

Phenylketonuria (PKU) - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 80 Pages
  • Global
From
Pompe Disease Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025 - Product Thumbnail Image

Pompe Disease Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • Report
  • September 2019
  • 100 Pages
  • Global
From
Sangamo Therapeutics Inc (SGMO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Sangamo Therapeutics Inc (SGMO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • January 2024
  • 89 Pages
From
Sangamo Biosciences Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Sangamo Biosciences Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • June 2024
  • 50 Pages
From
Comprehensive Report on Sangamo Therapeutics Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Sangamo Therapeutics Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Sangamo Therapeutics Inc (SGMO) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Sangamo Therapeutics Inc (SGMO) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • May 2023
  • 52 Pages
From
Loading Indicator